These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 16970925)

  • 1. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development.
    Dejardin E
    Biochem Pharmacol; 2006 Oct; 72(9):1161-79. PubMed ID: 16970925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide from Salmonella enterica activates NF-kappaB through both classical and alternative pathways in primary B Lymphocytes.
    Souvannavong V; Saidji N; Chaby R
    Infect Immun; 2007 Oct; 75(10):4998-5003. PubMed ID: 17698569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF.
    Yilmaz ZB; Weih DS; Sivakumar V; Weih F
    EMBO J; 2003 Jan; 22(1):121-30. PubMed ID: 12505990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
    Xiao G; Rabson AB; Young W; Qing G; Qu Z
    Cytokine Growth Factor Rev; 2006 Aug; 17(4):281-93. PubMed ID: 16793322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis.
    Soysa NS; Alles N; Weih D; Lovas A; Mian AH; Shimokawa H; Yasuda H; Weih F; Jimi E; Ohya K; Aoki K
    J Bone Miner Res; 2010 Apr; 25(4):809-18. PubMed ID: 19839765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
    Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
    APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods to assess the activation of the alternative (noncanonical) NF-κB pathway by non-death TNF receptors.
    Remouchamps C; Dejardin E
    Methods Mol Biol; 2015; 1280():103-19. PubMed ID: 25736746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways.
    Müller JR; Siebenlist U
    J Biol Chem; 2003 Apr; 278(14):12006-12. PubMed ID: 12556537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
    Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
    Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenes, tumor suppressors and p52 NF-kappaB.
    Perkins ND
    Oncogene; 2003 Oct; 22(48):7553-6. PubMed ID: 14576816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB p52, RelB and c-Rel are transported into the nucleus via a subset of importin alpha molecules.
    Fagerlund R; Melén K; Cao X; Julkunen I
    Cell Signal; 2008 Aug; 20(8):1442-51. PubMed ID: 18462924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
    Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
    Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling to NF-kappaB by Toll-like receptors.
    Kawai T; Akira S
    Trends Mol Med; 2007 Nov; 13(11):460-9. PubMed ID: 18029230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of late B cell differentiation by intrinsic IKKalpha-dependent signals.
    Mills DM; Bonizzi G; Karin M; Rickert RC
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6359-64. PubMed ID: 17404218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models.
    Gerondakis S; Grumont R; Gugasyan R; Wong L; Isomura I; Ho W; Banerjee A
    Oncogene; 2006 Oct; 25(51):6781-99. PubMed ID: 17072328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications.
    Espinosa I; Briones J; Bordes R; Brunet S; Martino R; Sureda A; Sierra J; Prat J
    Histopathology; 2008 Oct; 53(4):441-9. PubMed ID: 18983609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease.
    Enzler T; Bonizzi G; Silverman GJ; Otero DC; Widhopf GF; Anzelon-Mills A; Rickert RC; Karin M
    Immunity; 2006 Sep; 25(3):403-15. PubMed ID: 16973390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.